Interstitial pneumonitis related to rituximab therapy for Waldenström's macroglobulinemia

Clinical Case Reports

Xueyan Bai¹  Qu Cui¹ 

[1] Department of Hematology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China

关键词: Interstitial pneumonitis;    rituximab;    treatment;    Waldenström's macroglobulinemia;   

DOI  :  10.1002/ccr3.152

来源: Wiley

【 摘 要 】

Key Clinical Message

Rituximab-combined therapeutic regimens have been recommended for treatment of Waldenström's Macroglobulinemia (WM). We report one WM patient who developed interstitial pneumonitis after rituximab therapy.

【 授权许可】

CC BY-NC   
© 2014 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.

Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.